Brooke Hudspeth's guest appearances

Brooke Hudspeth

Behind the Blue

Best of News Talk 590 WVLK AM

David Rosenberg

Eli Capilouto

Melissa Hogan

Jennifer Hunter

Hannah Pittard

Christine Harper

Jason Brooks

Joe Monroe

Mark Williams

Jen Smith

Peter Nelson

Jill Smith

George Wright

Nicole Martin

Sarah Johnson

OwlTail

Vincent Venditto

LEXINGTON, Ky. (Dec. 9, 2020) – It has been nearly one year since the SARS-CoV-2 coronavirus changed the world. With millions of people infected and over a quarter million dead in the United States, the novel coronavirus continues its pervasive hold on our health and well-being. After months of stress, frustration and uncertainty, people are itching to travel and visit loved ones during the height of the holiday season, despite increasing cases of COVID-19. As the virus continues to dominate news coverage, people are clinging to the anticipation of promising vaccine trials from Pfizer, Moderna and several other companies. How will these vaccines, and potentially others still to come, change the course of the pandemic? Will we be able to return to normal and how long could that take? On this episode of Behind the Blue, we speak with Vincent Venditto, an assistant professor in the University of Kentucky College of Pharmacy’s Department of Pharmaceutical Science, and Brooke Hudspeth, an associate professor and Chief Practice Officer for the University of Kentucky College of Pharmacy. In our third and final part of this interview, we ask Vince and Brooke about how this pandemic possibly ends, and how we progress into a new world after COVID-19. "Behind the Blue" is available on iTunes, Google Play, Stitcher and Spotify. Become a subscriber to receive new episodes of “Behind the Blue” each week. UK’s latest medical breakthroughs, research, artists and writers will be featured, along with the most important news impacting the university. For questions or comments about this or any other episode of "Behind the Blue," email BehindTheBlue@uky.edu or tweet your question with #BehindTheBlue. To discover what’s wildly possible at the University of Kentucky, click here.

LEXINGTON, Ky. (Dec. 9, 2020) – It has been nearly one year since the SARS-CoV-2 coronavirus changed the world. With millions of people infected and over a quarter million dead in the United States, the novel coronavirus continues its pervasive hold on our health and well-being. After months of stress, frustration and uncertainty, people are itching to travel and visit loved ones during the height of the holiday season, despite increasing cases of COVID-19. As the virus continues to dominate news coverage, people are clinging to the anticipation of promising vaccine trials from Pfizer, Moderna and several other companies. How will these vaccines, and potentially others still to come, change the course of the pandemic? Will we be able to return to normal and how long could that take? On this episode of Behind the Blue, we speak with Vincent Venditto, an assistant professor in the University of Kentucky College of Pharmacy’s Department of Pharmaceutical Science, and Brooke Hudspeth, an associate professor and Chief Practice Officer for the University of Kentucky College of Pharmacy. In our third and final part of this interview, we ask Vince and Brooke about how this pandemic possibly ends, and how we progress into a new world after COVID-19. "Behind the Blue" is available on iTunes, Google Play, Stitcher and Spotify. Become a subscriber to receive new episodes of “Behind the Blue” each week. UK’s latest medical breakthroughs, research, artists and writers will be featured, along with the most important news impacting the university. For questions or comments about this or any other episode of "Behind the Blue," email <a href="mailto:BehindTheBlue@uky.edu">BehindTheBlue@uky.edu</a> or tweet your question with #BehindTheBlue. To discover what’s wildly possible at the University of Kentucky, click <a href="http://uknow.uky.edu/campus-news/igniting-passions-achieving-what-s-wildly-possible" rel="nofollow" target="_blank">here</a>.

December 9, 2020 - Vaccines, Part 3 with Vincent Venditto and Brooke Hudspeth

LEXINGTON, Ky. (Dec. 8, 2020) – It has been nearly one year since the SARS-CoV-2 coronavirus changed the world. With millions of people infected and over a quarter million dead in the United States, the novel coronavirus continues its pervasive hold on our health and well-being. After months of stress, frustration and uncertainty, people are itching to travel and visit loved ones during the height of the holiday season, despite increasing cases of COVID-19. As the virus continues to dominate news coverage, people are clinging to the anticipation of promising vaccine trials from Pfizer, Moderna and several other companies. How will these vaccines, and potentially others still to come, change the course of the pandemic? Will we be able to return to normal and how long could that take? On this episode of Behind the Blue, we speak with Vincent Venditto, an assistant professor in the University of Kentucky College of Pharmacy’s Department of Pharmaceutical Science, and Brooke Hudspeth, an associate professor and Chief Practice Officer for the University of Kentucky College of Pharmacy. In part two of our interview with Vince and Brooke, we discuss who exactly takes part in vaccine trials, the issues those trials may run into, when to expect some type of herd immunity and more. "Behind the Blue" is available on iTunes, Google Play, Stitcher and Spotify. Become a subscriber to receive new episodes of “Behind the Blue” each week. UK’s latest medical breakthroughs, research, artists and writers will be featured, along with the most important news impacting the university. For questions or comments about this or any other episode of "Behind the Blue," email BehindTheBlue@uky.edu or tweet your question with #BehindTheBlue. To discover what’s wildly possible at the University of Kentucky, click here.

LEXINGTON, Ky. (Dec. 8, 2020) – It has been nearly one year since the SARS-CoV-2 coronavirus changed the world. With millions of people infected and over a quarter million dead in the United States, the novel coronavirus continues its pervasive hold on our health and well-being. After months of stress, frustration and uncertainty, people are itching to travel and visit loved ones during the height of the holiday season, despite increasing cases of COVID-19. As the virus continues to dominate news coverage, people are clinging to the anticipation of promising vaccine trials from Pfizer, Moderna and several other companies. How will these vaccines, and potentially others still to come, change the course of the pandemic? Will we be able to return to normal and how long could that take? On this episode of Behind the Blue, we speak with Vincent Venditto, an assistant professor in the University of Kentucky College of Pharmacy’s Department of Pharmaceutical Science, and Brooke Hudspeth, an associate professor and Chief Practice Officer for the University of Kentucky College of Pharmacy. In part two of our interview with Vince and Brooke, we discuss who exactly takes part in vaccine trials, the issues those trials may run into, when to expect some type of herd immunity and more. "Behind the Blue" is available on iTunes, Google Play, Stitcher and Spotify. Become a subscriber to receive new episodes of “Behind the Blue” each week. UK’s latest medical breakthroughs, research, artists and writers will be featured, along with the most important news impacting the university. For questions or comments about this or any other episode of "Behind the Blue," email <a href="mailto:BehindTheBlue@uky.edu">BehindTheBlue@uky.edu</a> or tweet your question with #BehindTheBlue. To discover what’s wildly possible at the University of Kentucky, click <a href="http://uknow.uky.edu/campus-news/igniting-passions-achieving-what-s-wildly-possible" rel="nofollow" target="_blank">here</a>.

December 8, 2020 - Vaccines, Part 2 with Vincent Venditto and Brooke Hudspeth

LEXINGTON, Ky. (Dec. 7, 2020) – It has been nearly one year since the SARS-CoV-2 coronavirus changed the world. With millions of people infected and over a quarter million dead in the United States, the novel coronavirus continues its pervasive hold on our health and well-being. After months of stress, frustration and uncertainty, people are itching to travel and visit loved ones during the height of the holiday season, despite increasing cases of COVID-19. As the virus continues to dominate news coverage, people are clinging to the anticipation of promising vaccine trials from Pfizer, Moderna and several other companies. How will these vaccines, and potentially others still to come, change the course of the pandemic? Will we be able to return to normal and how long could that take? On this episode of Behind the Blue, we speak with two members of the UK College of Pharmacy all about the  history and implementation of vaccines, and what to expect from the rollout of these new vaccines designed to combat our current pandemic. Vincent Venditto is an assistant professor in the University of Kentucky College of Pharmacy’s Department of Pharmaceutical Science. Dr. Venditto received training in organic synthesis and vaccine development. He obtained a BS in chemistry from Gettysburg College and then worked for two years at the National Cancer Institute of the National Institutes of Health as a cancer research trainee before attending graduate school. He obtained a PhD in chemistry from Texas A&amp;M University and worked on vaccine development as an NIH postdoctoral fellow at University of California, San Francisco. Brooke Hudspeth is an associate professor and Chief Practice Officer for the University of Kentucky College of Pharmacy. An alumnus of the college’s PharmD and Community Residency programs, she serves as a preceptor for pharmacy students and residents, and as the CPO, oversees all community pharmacy efforts for the college while working to elevate the care available to those in the Commonwealth. "Behind the Blue" is available on iTunes, Google Play, Stitcher and Spotify. Become a subscriber to receive new episodes of “Behind the Blue” each week. UK’s latest medical breakthroughs, research, artists and writers will be featured, along with the most important news impacting the university. For questions or comments about this or any other episode of "Behind the Blue," email BehindTheBlue@uky.edu or tweet your question with #BehindTheBlue. To discover what’s wildly possible at the University of Kentucky, click here.

LEXINGTON, Ky. (Dec. 7, 2020) – It has been nearly one year since the SARS-CoV-2 coronavirus changed the world. With millions of people infected and over a quarter million dead in the United States, the novel coronavirus continues its pervasive hold on our health and well-being. After months of stress, frustration and uncertainty, people are itching to travel and visit loved ones during the height of the holiday season, despite increasing cases of COVID-19. As the virus continues to dominate news coverage, people are clinging to the anticipation of promising vaccine trials from Pfizer, Moderna and several other companies. How will these vaccines, and potentially others still to come, change the course of the pandemic? Will we be able to return to normal and how long could that take? On this episode of Behind the Blue, we speak with two members of the UK College of Pharmacy all about the  history and implementation of vaccines, and what to expect from the rollout of these new vaccines designed to combat our current pandemic. Vincent Venditto is an assistant professor in the University of Kentucky College of Pharmacy’s Department of Pharmaceutical Science. Dr. Venditto received training in organic synthesis and vaccine development. He obtained a BS in chemistry from Gettysburg College and then worked for two years at the National Cancer Institute of the National Institutes of Health as a cancer research trainee before attending graduate school. He obtained a PhD in chemistry from Texas A&amp;M University and worked on vaccine development as an NIH postdoctoral fellow at University of California, San Francisco. Brooke Hudspeth is an associate professor and Chief Practice Officer for the University of Kentucky College of Pharmacy. An alumnus of the college’s PharmD and Community Residency programs, she serves as a preceptor for pharmacy students and residents, and as the CPO, oversees all community pharmacy efforts for the college while working to elevate the care available to those in the Commonwealth. "Behind the Blue" is available on iTunes, Google Play, Stitcher and Spotify. Become a subscriber to receive new episodes of “Behind the Blue” each week. UK’s latest medical breakthroughs, research, artists and writers will be featured, along with the most important news impacting the university. For questions or comments about this or any other episode of "Behind the Blue," email <a href="mailto:BehindTheBlue@uky.edu">BehindTheBlue@uky.edu</a> or tweet your question with #BehindTheBlue. To discover what’s wildly possible at the University of Kentucky, click <a href="http://uknow.uky.edu/campus-news/igniting-passions-achieving-what-s-wildly-possible" rel="nofollow" target="_blank">here</a>.

December 7, 2020 - Vincent Venditto and Brooke Hudspeth (Vaccines - Part 1 of 3)